Homo sapiens (human): 6774
Help
Entry
6774 CDS
T01001
Symbol
STAT3, ADMIO, ADMIO1, APRF, HIES
Name
(RefSeq) signal transducer and activator of transcription 3
KO
K04692
signal transducer and activator of transcription 3
Organism
hsa
Homo sapiens (human)
Pathway
hsa01521
EGFR tyrosine kinase inhibitor resistance
hsa04062
Chemokine signaling pathway
hsa04066
HIF-1 signaling pathway
hsa04068
FoxO signaling pathway
hsa04217
Necroptosis
hsa04550
Signaling pathways regulating pluripotency of stem cells
hsa04630
JAK-STAT signaling pathway
hsa04659
Th17 cell differentiation
hsa04917
Prolactin signaling pathway
hsa04920
Adipocytokine signaling pathway
hsa04931
Insulin resistance
hsa04933
AGE-RAGE signaling pathway in diabetic complications
hsa04935
Growth hormone synthesis, secretion and action
hsa05145
Toxoplasmosis
hsa05160
Hepatitis C
hsa05161
Hepatitis B
hsa05162
Measles
hsa05163
Human cytomegalovirus infection
hsa05167
Kaposi sarcoma-associated herpesvirus infection
hsa05169
Epstein-Barr virus infection
hsa05171
Coronavirus disease - COVID-19
hsa05200
Pathways in cancer
hsa05203
Viral carcinogenesis
hsa05205
Proteoglycans in cancer
hsa05206
MicroRNAs in cancer
hsa05207
Chemical carcinogenesis - receptor activation
hsa05212
Pancreatic cancer
hsa05221
Acute myeloid leukemia
hsa05223
Non-small cell lung cancer
hsa05235
PD-L1 expression and PD-1 checkpoint pathway in cancer
hsa05321
Inflammatory bowel disease
hsa05417
Lipid and atherosclerosis
Network
nt06160
Human T-cell leukemia virus 1 (HTLV-1)
nt06162
Hepatitis B virus (HBV)
nt06164
Kaposi sarcoma-associated herpesvirus (KSHV)
nt06165
Epstein-Barr virus (EBV)
nt06167
Human cytomegalovirus (HCMV)
nt06219
JAK-STAT signaling
nt06262
Pancreatic cancer
nt06263
Hepatocellular carcinoma
nt06266
Non-small cell lung cancer
nt06276
Chronic myeloid leukemia
nt06518
JAK-STAT signaling
nt06527
Necroptosis
Element
N00053
Cytokine-Jak-STAT signaling pathway
N00094
EGF-Jak-STAT signaling pathway
N00095
ERBB2-overexpression to EGF-Jak-STAT signaling pathway
N00105
EML4-ALK fusion kinase to Jak-STAT signaling pathway
N00181
KSHV vIL-6 to Jak-STAT signaling pathway
N00415
IL10 family to Jak-STAT signaling pathway
N00416
HCMV vIL10 to IL10-JAK-STAT signaling pathway
N00486
EBV LMP1 to Jak-STAT signaling pathway
N00548
HBV HBx to Jak-STAT signaling pathway
N01340
ACH-CHRN-JAK-STAT signaling pathway
N01341
NNK/NNN to Jak-STAT signaling pathway
N01342
Nicotine to Jak-STAT signaling pathway
N01554
IL2 family to Jak-STAT signaling pathway
N01555
Hormone-like-cytokine to Jak-STAT signaling pathway
N01556
IL6 family to Jak-STAT signaling pathway
N01557
IL12/23 to Jak-STAT signaling pathway
N01559
Type II interferon to Jak-STAT signaling pathway
N01662
IFN-RIPK1/3 signaling pathway
Disease
H00016
Oral cancer
H00107
Other well-defined immunodeficiency syndromes
H01968
Hyper-IgE syndrome
H02540
Infantile-onset multisystem autoimmune disease
Drug target
Napabucasin:
D10717
Brite
KEGG Orthology (KO) [BR:
hsa00001
]
09130 Environmental Information Processing
09132 Signal transduction
04630 JAK-STAT signaling pathway
6774 (STAT3)
04066 HIF-1 signaling pathway
6774 (STAT3)
04068 FoxO signaling pathway
6774 (STAT3)
09140 Cellular Processes
09143 Cell growth and death
04217 Necroptosis
6774 (STAT3)
09144 Cellular community - eukaryotes
04550 Signaling pathways regulating pluripotency of stem cells
6774 (STAT3)
09150 Organismal Systems
09151 Immune system
04659 Th17 cell differentiation
6774 (STAT3)
04062 Chemokine signaling pathway
6774 (STAT3)
09152 Endocrine system
04920 Adipocytokine signaling pathway
6774 (STAT3)
04917 Prolactin signaling pathway
6774 (STAT3)
04935 Growth hormone synthesis, secretion and action
6774 (STAT3)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
6774 (STAT3)
05206 MicroRNAs in cancer
6774 (STAT3)
05205 Proteoglycans in cancer
6774 (STAT3)
05207 Chemical carcinogenesis - receptor activation
6774 (STAT3)
05203 Viral carcinogenesis
6774 (STAT3)
05235 PD-L1 expression and PD-1 checkpoint pathway in cancer
6774 (STAT3)
09162 Cancer: specific types
05212 Pancreatic cancer
6774 (STAT3)
05221 Acute myeloid leukemia
6774 (STAT3)
05223 Non-small cell lung cancer
6774 (STAT3)
09172 Infectious disease: viral
05161 Hepatitis B
6774 (STAT3)
05160 Hepatitis C
6774 (STAT3)
05171 Coronavirus disease - COVID-19
6774 (STAT3)
05162 Measles
6774 (STAT3)
05163 Human cytomegalovirus infection
6774 (STAT3)
05167 Kaposi sarcoma-associated herpesvirus infection
6774 (STAT3)
05169 Epstein-Barr virus infection
6774 (STAT3)
09174 Infectious disease: parasitic
05145 Toxoplasmosis
6774 (STAT3)
09163 Immune disease
05321 Inflammatory bowel disease
6774 (STAT3)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
6774 (STAT3)
09167 Endocrine and metabolic disease
04931 Insulin resistance
6774 (STAT3)
04933 AGE-RAGE signaling pathway in diabetic complications
6774 (STAT3)
09176 Drug resistance: antineoplastic
01521 EGFR tyrosine kinase inhibitor resistance
6774 (STAT3)
09180 Brite Hierarchies
09182 Protein families: genetic information processing
03000 Transcription factors [BR:
hsa03000
]
6774 (STAT3)
Transcription factors [BR:
hsa03000
]
Eukaryotic type
beta-Scaffold factors with minor groove contacts
STAT
6774 (STAT3)
BRITE hierarchy
SSDB
Ortholog
Paralog
Gene cluster
GFIT
Motif
Pfam:
STAT_alpha
STAT_bind
STAT_int
SH2
E2R135
Syntaxin-6_N
Fib_alpha
Motif
Other DBs
NCBI-GeneID:
6774
NCBI-ProteinID:
NP_644805
OMIM:
102582
HGNC:
11364
Ensembl:
ENSG00000168610
UniProt:
P40763
Structure
PDB
LinkDB
All DBs
Position
17:complement(42313324..42388442)
Genome browser
AA seq
770 aa
AA seq
DB search
MAQWNQLQQLDTRYLEQLHQLYSDSFPMELRQFLAPWIESQDWAYAASKESHATLVFHNL
LGEIDQQYSRFLQESNVLYQHNLRRIKQFLQSRYLEKPMEIARIVARCLWEESRLLQTAA
TAAQQGGQANHPTAAVVTEKQQMLEQHLQDVRKRVQDLEQKMKVVENLQDDFDFNYKTLK
SQGDMQDLNGNNQSVTRQKMQQLEQMLTALDQMRRSIVSELAGLLSAMEYVQKTLTDEEL
ADWKRRQQIACIGGPPNICLDRLENWITSLAESQLQTRQQIKKLEELQQKVSYKGDPIVQ
HRPMLEERIVELFRNLMKSAFVVERQPCMPMHPDRPLVIKTGVQFTTKVRLLVKFPELNY
QLKIKVCIDKDSGDVAALRGSRKFNILGTNTKVMNMEESNNGSLSAEFKHLTLREQRCGN
GGRANCDASLIVTEELHLITFETEVYHQGLKIDLETHSLPVVVISNICQMPNAWASILWY
NMLTNNPKNVNFFTKPPIGTWDQVAEVLSWQFSSTTKRGLSIEQLTTLAEKLLGPGVNYS
GCQITWAKFCKENMAGKGFSFWVWLDNIIDLVKKYILALWNEGYIMGFISKERERAILST
KPPGTFLLRFSESSKEGGVTFTWVEKDISGKTQIQSVEPYTKQQLNNMSFAEIIMGYKIM
DATNILVSPLVYLYPDIPKEEAFGKYCRPESQEHPEADPGSAAPYLKTKFICVTPTTCSN
TIDLPMSPRTLDSLMQFGNNGEGAEPSAGGQFESLTFDMELTSECATSPM
NT seq
2313 nt
NT seq
+upstream
nt +downstream
nt
atggcccaatggaatcagctacagcagcttgacacacggtacctggagcagctccatcag
ctctacagtgacagcttcccaatggagctgcggcagtttctggccccttggattgagagt
caagattgggcatatgcggccagcaaagaatcacatgccactttggtgtttcataatctc
ctgggagagattgaccagcagtatagccgcttcctgcaagagtcgaatgttctctatcag
cacaatctacgaagaatcaagcagtttcttcagagcaggtatcttgagaagccaatggag
attgcccggattgtggcccggtgcctgtgggaagaatcacgccttctacagactgcagcc
actgcggcccagcaagggggccaggccaaccaccccacagcagccgtggtgacggagaag
cagcagatgctggagcagcaccttcaggatgtccggaagagagtgcaggatctagaacag
aaaatgaaagtggtagagaatctccaggatgactttgatttcaactataaaaccctcaag
agtcaaggagacatgcaagatctgaatggaaacaaccagtcagtgaccaggcagaagatg
cagcagctggaacagatgctcactgcgctggaccagatgcggagaagcatcgtgagtgag
ctggcggggcttttgtcagcgatggagtacgtgcagaaaactctcacggacgaggagctg
gctgactggaagaggcggcaacagattgcctgcattggaggcccgcccaacatctgccta
gatcggctagaaaactggataacgtcattagcagaatctcaacttcagacccgtcaacaa
attaagaaactggaggagttgcagcaaaaagtttcctacaaaggggaccccattgtacag
caccggccgatgctggaggagagaatcgtggagctgtttagaaacttaatgaaaagtgcc
tttgtggtggagcggcagccctgcatgcccatgcatcctgaccggcccctcgtcatcaag
accggcgtccagttcactactaaagtcaggttgctggtcaaattccctgagttgaattat
cagcttaaaattaaagtgtgcattgacaaagactctggggacgttgcagctctcagagga
tcccggaaatttaacattctgggcacaaacacaaaagtgatgaacatggaagaatccaac
aacggcagcctctctgcagaattcaaacacttgaccctgagggagcagagatgtgggaat
gggggccgagccaattgtgatgcttccctgattgtgactgaggagctgcacctgatcacc
tttgagaccgaggtgtatcaccaaggcctcaagattgacctagagacccactccttgcca
gttgtggtgatctccaacatctgtcagatgccaaatgcctgggcgtccatcctgtggtac
aacatgctgaccaacaatcccaagaatgtaaacttttttaccaagcccccaattggaacc
tgggatcaagtggccgaggtcctgagctggcagttctcctccaccaccaagcgaggactg
agcatcgagcagctgactacactggcagagaaactcttgggacctggtgtgaattattca
gggtgtcagatcacatgggctaaattttgcaaagaaaacatggctggcaagggcttctcc
ttctgggtctggctggacaatatcattgaccttgtgaaaaagtacatcctggccctttgg
aacgaagggtacatcatgggctttatcagtaaggagcgggagcgggccatcttgagcact
aagcctccaggcaccttcctgctaagattcagtgaaagcagcaaagaaggaggcgtcact
ttcacttgggtggagaaggacatcagcggtaagacccagatccagtccgtggaaccatac
acaaagcagcagctgaacaacatgtcatttgctgaaatcatcatgggctataagatcatg
gatgctaccaatatcctggtgtctccactggtctatctctatcctgacattcccaaggag
gaggcattcggaaagtattgtcggccagagagccaggagcatcctgaagctgacccaggt
agcgctgccccatacctgaagaccaagtttatctgtgtgacaccaacgacctgcagcaat
accattgacctgccgatgtccccccgcactttagattcattgatgcagtttggaaataat
ggtgaaggtgctgaaccctcagcaggagggcagtttgagtccctcacctttgacatggag
ttgacctcggagtgcgctacctcccccatgtga
DBGET
integrated database retrieval system